With 0.56 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.75 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.6897 whereas the lowest price it dropped to was $0.5855. The 52-week range on IINN shows that it touched its highest point at $2.45 and its lowest point at $0.54 during that stretch. It currently has a 1-year price target of $13.00. Beta for the stock currently stands at 2.12.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IINN was up-trending over the past week, with a rise of 2.78%, but this was down by -15.82% over a month. Three-month performance dropped to -42.04% while six-month performance fell -54.79%. The stock lost -70.88% in the past year, while it has lost -39.76% so far this year.
Float and Shares Shorts:
At present, 25.62 million IINN shares are outstanding with a float of 23.89 million shares on hand for trading. On 2025-03-31, short shares totaled 74478.0, which was 28.999999999999996 higher than short shares on 1740700800. In addition to Mr. Dagi Shahar Ben-Noon as the firm’s Co-Founder, CEO & Director, Mr. Joe Hayon serves as its Co-Founder, President & Director.
Institutional Ownership:
Through their ownership of 0.04551 of IINN’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.7 being high and -$0.7 being low. For IINN, this leads to a yearly average estimate of -$0.7.
